Jason Ehrlich

2021

In 2021, Jason Ehrlich earned a total compensation of $27.9M as Chief Medical Officer and Chief Development Officer at Kodiak Sciences, a 814% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$254,948
Option Awards$25,844,150
Salary$479,000
Stock Awards$1,323,150
Other$45,303
Total$27,946,551

Ehrlich received $25.8M in option awards, accounting for 92% of the total pay in 2021.

Ehrlich also received $254.9K in non-equity incentive plan, $479K in salary, $1.3M in stock awards and $45.3K in other compensation.

Rankings

In 2021, Jason Ehrlich's compensation ranked 174th out of 12,415 executives tracked by ExecPay. In other words, Ehrlich earned more than 98.6% of executives.

ClassificationRankingPercentile
All
174
out of 12,415
99th
Division
Manufacturing
46
out of 5,505
99th
Major group
Chemicals And Allied Products
16
out of 2,375
99th
Industry group
Drugs
12
out of 2,096
99th
Industry
Biological Products, Except Diagnostic Substances
8
out of 449
98th
Source: SEC filing on April 25, 2023.

Ehrlich's colleagues

We found two more compensation records of executives who worked with Jason Ehrlich at Kodiak Sciences in 2021.

2021

Victor Perlroth

Kodiak Sciences

Chief Executive Officer

2021

John Borgeson

Kodiak Sciences

Chief Financial Officer

News

In-depth

You may also like